<\/p>\n
\u00a0Axiomatic\u00a0<\/strong>\u2013 <\/b>A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel (AXIOMATIC-SSP)<\/b><\/p>\n CHARM \u00a0<\/strong>\u2013<\/b>\u00a0Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large<\/b><\/p>\n ETHICHS \u00a0<\/strong>\u2013<\/b><\/a>\u00a0Esmolol for the Treatment of Hypertension after Intracerebral Hemorrhage Study\u00a0<\/b><\/p>\n INTERACT-3<\/a> \u00a0\u2013 <\/span><\/b>The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial\u00a0<\/b><\/p>\n OPTIMAL STROKE \u2013 <\/span><\/b><\/a>Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Stroke Patients<\/b><\/p>\n Resilient Direct TNK \u2013 <\/b><\/span><\/strong>R<\/b>andomization to <\/b>E<\/b>ndoVascular Treatment Alone or Preceded by <\/b>S<\/b>ystemic Thrombolysis with Tenecteplase in Acute <\/b>I<\/b>schemic Stroke due to <\/b>L<\/b>arge <\/b>I<\/b>ntracranial V<\/b>E<\/b>ssel Occlusio<\/b>N<\/b> T<\/b>rial \u2013<\/b>DIRECT<\/b> Thrombectomy vs. intravenous <\/b>TNK<\/b> plus thrombectomy\u00a0<\/b><\/p>\n Resilient Extend \u2013 <\/span><\/strong>Randomization of Endovascular Treatment with Stent-retriever and\/or Thromboaspiration vs. Best Medical Therapy in Acute Ischemic Stroke due to Large VEssel OcclusioN Trial in the Extended Time Window (RESILIENT- Extend)<\/b><\/p>\n Resilient Extend IV (in\u00edcio) \u2013 <\/strong><\/span><\/b>R<\/b>andomization to <\/b>E<\/b>xtend <\/b>S<\/b>troke <\/b>I<\/b>ntravenous Thrombo<\/b>L<\/b>ysis <\/b>I<\/b>n <\/b>E<\/b>volving <\/b>N<\/b>on-Large Vessel Occlusion with <\/b>T<\/b>NK (RESILIENT- Extend-IV)<\/b><\/p>\n TRIDENT <\/a>\u00a0\u00a0\u2013 <\/span>Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial. <\/b><\/p>\n Tempo 2<\/strong> \u2013<\/b>\u00a0A Phase 3, Multi-Arm Multi-Stage Covariate-Adjusted Response-Adaptive Randomised Trial to Determine Optimal Early Mobility Training after Stroke (AVERT DOSE)<\/b><\/span><\/p>\n Avert-Dose <\/strong>\u2013 A trial to Determine the Optimal early mobility Training after StrokE<\/b><\/span>\u00a0<\/b><\/p>\n REGISTRO DE INDICADORES DE QUALIDADE DE AVC NO BRASIL<\/strong><\/p>\n <\/p>\n BASICS <\/b><\/a>– <\/b>Basilar Artery International Cooperation Study<\/b><\/p>\n BRIDGE-STROKE<\/b><\/a> <\/b>\u2013 <\/b>Brazi<\/b>lian inteRvention to Increase eviDence usaGe in practicE <\/b>\u2013 <\/b>Stroke<\/b><\/p>\n ENCHANTED <\/b><\/a>\u2013 <\/b>Enchanced Control of Hypertension and Thrombolysis Stroke Stud<\/b>y<\/b><\/p>\n HeadPoST \u00a0<\/b><\/a>\u2013 \u00a0<\/b>Head Position in Stroke Trial<\/b>.\u00a0<\/b><\/p>\n RESILIENT<\/a> <\/b>\u2013 <\/b>Randomization of EndoVascular Treatment with Solitaire<\/i><\/b> FR\u00ae vs. <\/b>Best Medical Therapy in Acute Ischemic Stroke due to Large VEssel OcclusioN Trial<\/i><\/b>)<\/b><\/p>\n THALES<\/b><\/a> – Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death<\/b><\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" Ongoing Trials\u00a0 \u00a0Axiomatic\u00a0\u2013 A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel (AXIOMATIC-SSP) CHARM \u00a0\u2013\u00a0Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large ETHICHS \u00a0\u2013\u00a0Esmolol for the Treatment of Hypertension after Intracerebral Hemorrhage Study\u00a0 INTERACT-3 \u00a0\u2013 The[…]<\/a><\/p>\n","protected":false},"author":906,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-829","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/sites.usp.br\/rnpavc\/wp-json\/wp\/v2\/pages\/829","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sites.usp.br\/rnpavc\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.usp.br\/rnpavc\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.usp.br\/rnpavc\/wp-json\/wp\/v2\/users\/906"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.usp.br\/rnpavc\/wp-json\/wp\/v2\/comments?post=829"}],"version-history":[{"count":4,"href":"https:\/\/sites.usp.br\/rnpavc\/wp-json\/wp\/v2\/pages\/829\/revisions"}],"predecessor-version":[{"id":1013,"href":"https:\/\/sites.usp.br\/rnpavc\/wp-json\/wp\/v2\/pages\/829\/revisions\/1013"}],"wp:attachment":[{"href":"https:\/\/sites.usp.br\/rnpavc\/wp-json\/wp\/v2\/media?parent=829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n\n
Finished Trials and Respective Publications<\/b><\/h3>\n
\n
\n
\n
\n
\n
\n